This Week on NeurologyLive — May 10, 2021


Here's what is coming soon to NeurologyLive.

Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week. As always, our weekly coverage extends beyond just these topics, so make sure to check out the rest of the site!

This week, new episodes of the NeurologyLive Insights series, "The Patient-Centered Visit & Shared Decision Making in the Management of Migraine," featuring Jill Dehlin, RN, a certified health education specialist, patient advocate, and a person with migraine, and Amaal J. Starling, MD, a neurologist specializing in migraine from the Mayo Clinic in Phoenix, Arizona. The pair provides insight to incorporate patient-centered visits into a headache and migraine practice.

To catch up on the series, click here.

On Tuesday, be sure to check out the MJH Life Sciences Medical World News channel, as a number of new shows featuring your peers and colleagues in medicine will air! This week, on May 11, NeurologyLive will appear on the new show "Deep Dive." The episode will feature senior editor Matt Hoffman speaking with Daniel Claassen, MD, MS, director, Huntington’s Disease Clinic, and division chief, Behavioral and Cognitive Neurology, Vanderbilt University Medical Center, about the recent news of trial program terminations from Roche and Wave Life Science, and the hope that remains in the Huntington disease pipeline despite these setbacks.

To check out what's on the Medical World News channel now, click here.

The latest in our NeuroVoices series, dedicated to conversations with leaders in the neurology community, goes live on Wednesday, May 12. This week's features Eric Leuthardt, MD, chief, Division of Neurotechnology, Washington University School of Med in St. Louis, who shared insight into the recently approved IspiHand System for stroke rehabilitation. He discussed the patient population most likely to benefit, what else the system may be capable of aiding in treatment, and how it may be streamlined into clinical care.

To check out the prior NeuroVoices conversations, click here.

Throughout the week, the NeurologyLive Peer Exchange series, "Strategies in Treating Relapsing-Remitting Multiple Sclerosis," will add additional episodes. The series features a panel of individuals including moderator Scott Newsome, DO, MSCS, FAAN; as well as Patricia K. Coyle, MD, Robert Fox, MD, and Clyde E. Markowitz, MD, who thus far have discussed the diagnosis of patients, differentiation of disease phases, therapeutic approaches, and counseling for patients, among other topics.

To catch up on the series, click here.

As a reminder, the April 2021 print issue of NeurologyLive is now available on our website. Some of the feature pieces included are "Magnetic Resonance’s Impact on Diagnosis, Prognostication, and Therapeutic Approaches in Neuromuscular Disorders," by Kenneth Bender, PharmD, MA; "A Critical Evaluation of Disease-Modifying Strategies in Parkinson Disease," by Fernando L. Pagan, MD, Charbel Moussa, MBBS, PhD, and Yasar Torres-Yaghi, MD; and "Neurosurgery and Parkinson Disease: Past, Present, and Future of Deep Brain Stimulation," by Atom Sarkar, MD, PhD, among others.

To view the issue in digital form, click here.

Related Videos
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
Michael Kaplitt, MD, PhD
video 4 - "Amyloid Cascade Hypothesis of Alzheimer’s Disease"
Video 3 - "Amyloid Precursor Protein and Amyloid Beta Species in Alzheimer’s Disease"
Svetlana Blitshteyn, MD, FAAN, director and founder of Dysautonomia Clinic
© 2024 MJH Life Sciences

All rights reserved.